tapebrief
LYB · Q4 2025
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

LYB · Q1 2026 Earnings

LyondellBasell

Reported May 1, 2026

30-second summary

SENTIMENT: Cautiously positive Revenue of $7.20B (-6.2% YoY, +1.5% QoQ) and EBITDA ex-identified items of $615M mark a sharp sequential rebound from Q4 2025's $417M (+47% QoQ) and a step up from Q1 2025's $576M. Management frames the quarter as "sequential improvement…driven by operational discipline and commercial execution," with the Middle East war materially steepening the global petrochemical cost curve in favor of LYB's advantaged North American assets. Forward framing is constructive: European O&P operating rates raised to 80% for Q2, North America margin expansion anticipated on export demand and crude-linked pricing, and "significant sequential improvement across almost all businesses" guided. The YoY revenue decline largely reflects discontinued refinery operations and the completed European asset sale, not demand collapse.

Headline numbers

EPS

Q1 FY2026

$0.49

Revenue

Q1 FY2026

$7.20B

-6.2% YoY

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$7.20B-6.2%$30.15B-76.1%
EPS$0.49—$1.70-71.2%

Guidance

Full-year 2026 cash and capex targets reaffirmed; Q2 FY2026 expected to show significant sequential EBITDA improvement with European operating rates raised to 80%.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

MetricPeriodGuideYoY
Effective Tax RateFY 2026Approximately 10%—
Olefins & Polyolefins - Americas Operating RateQ2 FY2026Further expansion anticipated; specific rate not quantified in current guidance—
Olefins & Polyolefins - EAI Operating RateQ2 FY202680% for European O&P assets—
Intermediates & Derivatives Operating RateQ2 FY202675%—
Sequential EBITDA ImprovementQ2 FY2026Significant improvement expected across almost all businesses—

Reaffirmed unchanged this quarter: Capital Expenditures (Approximately $1.2 billion), Cash Improvement (incremental vs 2025) ($500 million incremental cash expected in 2026)

Other KPIs

Q1 FY2026
SegmentQ1 FY2026
EBITDA (excluding identified items)$615 million
Operating Cash Flow$(269) million
Capital Expenditures$269 million
Cash and Cash Equivalents$2.6 billion
Total Liquidity$7.3 billion
Shareholder Returns (Dividends)$224 million

Management tone

Narrative arc: Q2 2025 cash preservation pivot → Q3 2025 monitored stabilization → Q4 2025 controlled optimism on operational delivery (with management characterizing 2025 as "some of the most challenging market conditions I have seen in my career") → Q1 FY2026 explicit pivot to capturing upside from a steeper global cost curve following Middle East war disruption.

The cycle framing has shifted toward opportunity capture on a steeper cost curve. The Q1 FY2026 press release leads with: "The global cost curve for petrochemicals has materially steepened with the onset of war in the Middle East and is unlikely to revert to pre-war conditions anytime soon. LYB is moving quickly and decisively to increase production to help fill the gap in global supply…We are leveraging the lowest delivered cost with advantaged assets in North America and passing through higher raw material costs in Europe." This is a categorically more constructive forward framing than the Q4 2025 call's emphasis on navigating a prolonged trough, though management continues to acknowledge the downturn is long-running.

Forward Q2 framing is genuinely constructive. European O&P operating rates raised to 80% (from 75% in Q1), "significant sequential EBITDA improvement" expected across almost all businesses, and North America margin expansion driven by export demand and crude-linked pricing dynamics. Reduced Middle East/Asia exports to Europe and the steeper global cost curve are framed as tailwinds. Management explicitly states: "With cost-advantaged assets and operating leverage, LYB is well-positioned to profit from the steeper global cost curve for petrochemicals."

Portfolio transformation milestone reached. The sale of four European assets has completed, which management says leaves LYB "better positioned with increased resilience and greater flexibility to capture market upside by leveraging a greater proportion of its portfolio's low-cost production." Q2 will be the first quarter reflecting the post-divestiture footprint.

Capital allocation discipline maintained. The press release describes Q1 capital allocation as "balanced between capital expenditures of $269 million and $224 million of shareholder returns through dividends," with continued focus on the Cash Improvement Plan, capex discipline, and working capital optimization. The investment-grade balance sheet remains foundational per prior management guidance.

Recurring themes management leaned on this quarter:

Prolonged industry downturn with margins 45% below historical averagesCash generation discipline and working capital optimization (95% conversion ratio)Value Enhancement Program extended to $1.5B target by 2028Deferral of growth capex; prioritizing low/no-cost projects and Moritech OneCapacity rationalization accelerating globally (23M tons identified)Positioning for value capture once cycle recovers

Risks management surfaced:

Global trade disruptions and tariff uncertainty affecting marketsStructural overcapacity in China and Asia pending anti-involution policy outcomesIncreased competition from low-cost imports in EuropeStructurally higher energy costs in EuropeWeak demand in durable goods and automotive sectorsGeopolitical uncertainty affecting oil and crude pricing

Answers to last quarter's watch list

Whether Q1 actual operating rates came in above the guided 85% / 75% / 85%. Actual segment-level Q1 operating rates were not disclosed in the press release. Forward Q2 guides — European O&P raised to 80% (from 75% Q1 guide) and I&D set at 75% (vs. 85% guided for Q1) — suggest mixed read-through: European O&P momentum is building, while I&D rates step down. Status: Partially resolved.
Whether FY2026 revenue or EBITDA guidance is initiated. Not initiated. FY2026 guidance remains limited to effective tax rate (~10%); prior capex and cash-improvement figures were not explicitly restated in the Q1 release. Status: Resolved negatively — the absence persists.
Cash Improvement Plan trajectory toward $1.3B by end-2026. The Q1 release references "cash improvement in 2026" qualitatively but does not restate the $500M incremental or $1.3B cumulative target. Q1 operating cash flow of -$269M reflects a typical working capital build; execution remains back-end-loaded. Status: Continue monitoring — not addressed numerically in Q1 release.
Polyethylene price increase implementation in Q1. Confirmed as supportive: O&P Americas EBITDA doubled QoQ with "accelerating product prices" benefiting PE margins, and Middle East war tightness "supported higher polyethylene prices in both domestic and export markets." Status: Resolved positively.
European divestiture close. Completed — the press release confirms "completion of the sale of four European assets." Status: Resolved positively.
Dividend coverage by organic FCF. Q1 organic FCF was deeply negative (operating cash flow -$269M, capex $269M, dividend paid $224M), reflecting the seasonal working capital build. The press release does not address dividend policy changes; management continues to characterize capital allocation as balanced. Status: Continue monitoring.
Whether the MoReTec-2 FID is finally decided or pushed again. Per prior-quarter management commentary, MoReTec-2 remains in the "as markets recover" bucket. The Q1 FY2026 press release does not update FID timing. Status: Continue monitoring.

What to watch into next quarter

Whether Q2 EBITDA shows the "significant sequential improvement" guided. With Q1 ex-items EBITDA at $615M, a credible "significant" lift would mean Q2 prints meaningfully above $700M. Anything flat-to-down would imply the forward narrative is not landing.

European O&P actual Q2 operating rate vs. the 80% guide. This is the cleanest read on whether reduced Middle East/Asia exports to Europe are creating the spread tailwind management is describing. A miss would undermine the "steeper global cost curve" thesis.

North America margin expansion realization. Management is guiding to further expansion on export demand and crude-linked pricing. Watch O&P Americas EBITDA progression against the doubled Q1 sequential print.

European divestiture financial impact. The completed sale is expected to "improve average margins while reducing cost." Watch for transaction proceeds disclosure, segment margin reset, and how capital is deployed.

I&D recovery on Bayport restart and acetyls normalization. Q1 was impacted by the Bayport PO/TBA outage (started March) and delayed La Porte acetyls restart. Watch for resolution and the implied EBITDA recapture.

Cash Improvement Plan execution. Watch for explicit Q2 restatement of the $500M FY2026 increment and $1.3B cumulative target, and for cash generation to inflect after the Q1 working capital build.

MoReTec-2 FID and Flex-2 status. Both remain contingent on cycle recovery per prior guidance. Any movement on revised timing — or formal cancellation — would be material.

Sources

  1. LyondellBasell Q1 2026 press release, SEC filing — https://www.sec.gov/Archives/edgar/data/1489393/000148939326000025/a2026q1ex991_pressrelease.htm
  2. LyondellBasell prior-quarter (Q4 2025) management commentary, for tone arc and prior-guidance reference only

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.